Flumadine (Caraco Pharma, Inc.)


Welcome to the PulseAid listing for the Flumadine drug offered from Caraco Pharma, Inc.. This Influenza A M2 Protein Inhibitor [EPC],M2 Protein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Caraco Pharma, Inc.
NON-PROPRIETARY NAME: flumadine
SUBSTANCE NAME: RIMANTADINE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Influenza A M2 Protein Inhibitor [EPC],M2 Protein Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2009-09-22
END MARKETING DATE: 0000-00-00


Flumadine HUMAN PRESCRIPTION DRUG Details:

Item DescriptionFlumadine from Caraco Pharma, Inc.
LABELER NAME: Caraco Pharma, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/1)
START MARKETING DATE: 2009-09-22
END MARKETING DATE: 0000-00-00
PRODUCT ID: 49708-521_3f2752c1-89c7-483d-a974-e47b75ffa259
PRODUCT NDC: 49708-521
APPLICATION NUMBER: NDA019649

Other RIMANTADINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Bryant Ranch PrepackRimantadine Hydrochloride
Caraco Pharma, Inc.Flumadine
Carilion Materials ManagementRimantadine Hydrochloride
H.J. Harkins Company, Inc.Rimantadine Hydrochloride
Impax GenericsRimantadine Hydrochloride
STAT Rx USA LLCRimantadine Hydrochloride